Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen‐Activated Protein Kinase Pathway Alterations.

MLA

Boisseau, William, et al. “Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen‐Activated Protein Kinase Pathway Alterations.” Oncologist, vol. 24, no. 12, Dec. 2019, pp. 1584–92. EBSCOhost, https://doi.org/10.1634/theoncologist.2019-0223.

APA

Boisseau, W., Euskirchen, P., Mokhtari, K., Dehais, C., Touat, M., Hoang, X. K., Sanson, M., Capelle, L., Nouet, A., Karachi, C., Bielle, F., Guégan, J., Marie, Y., Martin, D. N., Taillandier, L., Rousseau, A., Delattre, J., & Idbaih, A. (2019). Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen‐Activated Protein Kinase Pathway Alterations. Oncologist, 24(12), 1584–1592. https://doi.org/10.1634/theoncologist.2019-0223

Chicago

Boisseau, William, Philipp Euskirchen, Karima Mokhtari, Caroline Dehais, Mehdi Touat, Xuan, Khê Hoang, Marc Sanson, et al. 2019. “Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen‐Activated Protein Kinase Pathway Alterations.” Oncologist 24 (12): 1584–92. doi:10.1634/theoncologist.2019-0223.